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Abstract 
Randomized controlled trials in surgery are notoriously difficult to design and conduct, due 
to numerous methodological and cultural challenges. Over the last five years, several UK-
based surgical trial-related initiatives have been funded to address these issues. These 
include the development of Surgical Trials Centers and Surgical Specialty Leads (individual 
surgeons responsible for championing RCTs in their specialist fields), both funded by the 
Royal College of Surgeons of England; networks of research-active surgeons in training; and 
investment in methodological research relating to surgical RCTs (to address issues such as 
recruitment, blinding, and the selection and standardization of interventions). This paper 
discusses these initiatives in more detail and provides exemplar cases to illustrate how the 
methodological challenges have been tackled. The initiatives have surpassed expectations, 
resulting in a renaissance in surgical research throughout the UK, such that the number of 
patients entering surgical RCTs has doubled.  
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Introduction 
In 1996 Richard Horton, editor of the Lancet, published a disparaging editorial about the 
quality of surgical research, parodying it as a ‘comic opera’.1 He highlighted that most 
published research papers were single surgeon case series, and criticized surgeons’ limited 
insight about the weakness of this study design in establishing causation. Combined with a 
lack of collaborative working – ‘…the personal attributes that go to make a successful 
surgeon differ from those needed for…multicentre research’ - he postulated that specific 
methodological challenges unique to the evaluation of surgical interventions may explain the 
lack of randomized controlled trials (RCTs) in this field. Many of these challenges relate to 
the fact that surgical procedures are complex healthcare interventions,2 meaning that ‘unlike 
20 milligram tablets, no two surgical procedures are the same’ and achieving standardization 
of interventions within RCTs is difficult.3 Challenges for evaluation arise from surgeons’ 
personal preferences, as well as their skill levels and ability to learn new techniques. Surgical 
procedures also involve other team members (i.e. anesthetists, surgical assistants, nurses) 
and associated pre, peri- and post-operative interventions, all of which may influence the 
overall outcome of an operation. Moreover, surgery is constantly evolving and it has been 
said of surgery that it is always ‘too early [for rigorous evaluation such as a trial] until, 
unfortunately, it’s suddenly too late’.4 Other challenges include achieving blinding of 
surgeons and other caregivers, and appropriate outcome selection; there is a tendency for 
surgeons to put great emphasis upon early technical adverse events and focus less on longer 
term patient-centered outcomes.5  
In the years following Horton’s editorial, the number and quality of trials in surgery initially 
remained poor.6-8 Less than 10% of published articles in surgical journals are classified as 
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RCTs and systematic reviews summarizing the quality of RCTs in surgery have shown little 
improvement.6 Whilst the figures for other specialties are not easily available, a 
conventional evidence base is lacking for much of surgical practice; in the absence of 
evidence, surgeons have continued to perform operations according to their preferred 
methods and surgical approaches and strategies for similar conditions vary widely.9 
In the US and UK, government funded research bodies (National Institute for Health and 
National Institute for Health Research) have pledged to improve their nations’ health and 
wealth through research and increasing access to research studies.10 This vision includes the 
many patients undergoing planned or unscheduled surgical procedures; evidence-based 
surgical practice is critical and surgical trials should be a key part of achieving this. Over the 
last five years, the UK has begun a major research investment in this field. This paper 
describes the main UK based surgical trial-related initiatives that have started and are 
contributing to this initiative. It also outlines some ways in which the methodological 
challenges in RCTs in surgery may be tackled. 
 
Investment in evidence based surgery 
 
Creation and support of Surgical Trials Centers 
The Royal College of Surgeons of England has led an initiative aimed at developing an 
infrastructure for surgical research.11 The main components include investment in Surgical 
Trials Centers and Surgical Specialty Leads (individual surgeons responsible for championing 
RCTs in their specialist fields). Five centers – selected through a competitive national 
selection process – were awarded funding in 2013; a sixth joined the network in 2015 and a 
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seventh is planned for 2016. All are embedded in clinical trials units that are part of a UK 
network of units meeting specified criteria12 and link to the Surgical Specialty Leads (Figure 
1). Core funding for the centers facilitates i) collaborations between surgeons and trial 
methodologists to develop new trials, ii) mentoring of new chief and principal investigators 
and iii) provision of expertise to engage, educate and encourage teamwork among surgeons 
across a wide range of hospitals. The centers’ progress is monitored carefully against 
ambitious targets, which aim (at a minimum) to develop three new investigators and two 
new studies each year. To date, the initiative has surpassed expectations. In the last three 
years, 57 RCTs in surgery have been initiated, producing 175 new chief and principal 
investigators, an increase in the number of hospitals recruiting into surgical studies, and 
double the number of patients entering surgical RCTs (25,500 in 2014-15 compared with 
11,000 in 2011-12).13 The creation of Surgical Trials Centers was timely because it coincided 
with a commissioned call for surgical research led by the National Institute for Health 
Research. The research teams and centers worked together, resulting in an £18m 
investment into RCTs in surgery.  
 
Surgical Specialty leads  
The Royal College of Surgeons provided funding for 15 surgical specialty leads to work with 
the Trials Centers in developing trials, encouraging networking and providing research-based 
education for attendings and residents in each surgical specialty. The process was 
competitive, with each lead appointed in conjunction with leaders from the corresponding 
specialty society (for example, the upper gastrointestinal lead was selected by the Royal 
College of Surgeons and leaders of the Association of Upper Gastrointestinal Surgeons). 
These links have provided opportunities for high profile plenary presentations at national 
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conferences, as well as a resource for other surgeons to engage and work with. The surgical 
specialty lead for coloproctology, for example, led a large-scale research prioritization 
exercise: initially, members of the Association of Coloproctologists of Great Britain and 
Ireland submitted over 500 research ideas for consideration; these were reduced into a final 
list of 15 cancer and 10 non-cancer research questions, using modified Delphi methodology 
involving surgeons, nurses, patients, researchers and industry representatives.14 Some of the 
SSLs use their funding to support feasibility work to inform RCTs, and to link with surgical 
residents to work together in designing and conducting studies.  
 
Research within surgical training 
In parallel with the renaissance in research led by the Royal College of Surgeons, surgeons in 
training have reinvented ground-level multicenter research. Surgical residents across the UK 
have developed collaborative networks, such that nearly all regions of the UK now boast a 
trainee-led research collaborative.15,16 The smaller subspecialties (such as pediatrics, 
neurosurgery and cardiac surgery) have formed similar networks on a national (rather than 
regional) scale.17 Trainee members of collaboratives are working together, both within and 
across the regions, to design and conduct multicenter randomized and observational studies. 
Their ability to work together to recruit patients means that large scale studies can 
increasingly be carried out by mobilizing a large number of people in a short time. The first 
trainee-led RCT recruited over 700 patients from 21 centers and finished over a year ahead 
of schedule,18 setting an ambitious target for future studies which at least one other has 
achieved.19 Whether this model is truly transferable to different clinical areas and research 
studies is uncertain; however, the creation of a workforce who participate and understand 
trials has huge potential positive benefit for future consultant surgeons and research. 
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Trainee-led observational studies (which have included as many as 165 centers and over 
8,900 patients)20 have quantified differences in practice between surgeons, centers and 
regions, leading to the identification of evidence gaps and ideas for future RCTs. Another 
benefit of trainee-led research collaboratives is that they are developing future capacity with 
expertise in trial design and methodology. This means that even difficult trials can be tackled 
because of the increased levels of trials expertise and willingness to work in research teams. 
Thus, the culture of UK surgical research is changing rapidly from being competitive to being 
collaborative, countering Horton’s views about surgeons’ inability to work together.21 
 
Developing and implementing methods to improve the design and delivery of 
RCTs in surgery 
Surgical trials face particular difficulties. These include challenges with recruitment, 
intervention design and delivery, and outcome selection and measurement. In the UK, in 
parallel with the initiatives described above, there has been investment in methodological 
research to facilitate and enhance RCTs. The UK Medical Research Council created a Network 
of regional Hubs for Trials Methodology Research.22 One of these - the Collaboration and 
innovation in Difficult and Complex randomized controlled Trials In Invasive procedures 
Hub23 - specifically tackles methodological issues in trials of complex interventions, with a 
focus on surgery. The Hub is co-located with the Royal College of Surgeons Trials Centre in 
Bristol and is therefore in a unique position to deploy diverse methods to enhance new trials 
and monitor and evaluate their impact. It also provides a focus of expertise and clinical 
leadership, bringing surgeons and methodologists together to increase capacity in this field. 
The Hub works closely with the two registered clinical trials units in Bristol,24, 25 other 
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regional and national clinical trials units26, 27 and the regional trainee research 
collaborative.16 Its major themes in surgical RCTs include the application of methods to 
optimize recruitment, improve pre-trial pilot and feasibility work, and outcome selection. 
Benefits include estimating the size of eligible populations and recruitment rates, developing 
outcome measures, exploring the feasibility of blinding, selecting appropriate interventions 
and determining their acceptability. These are described below, using examples from 
completed or ongoing studies.  
 
Recruitment 
There are many obstacles and hidden challenges to randomizing patients into surgical 
RCTs.28 Historically, recruitment problems were widespread with approximately only 50% of 
surgical RCTs reaching scheduled targets.29 One reason for this may be that diverse 
treatments are sometimes compared (e.g. surgical versus non-surgical interventions), which 
creates difficulties due to personal views that one treatment is better than another despite a 
lack of evidence to confirm this.30 It may also occur because surgeons are not familiar with 
recruiting patients into RCTs. In the Hub, methods have been developed (the Quintet 
Recruitment Intervention) to overcome these problems.31 This uses mixed methods to 
observe the recruitment process and the way information is communicated to participants. 
Following this, educational sessions and individual feedback, explaining how information can 
be communicated more impartially and preferences probed, are provided. This approach has 
been used successfully in the By-Band-Sleeve study (case study 1), in which there were pre-
existing treatment preferences amongst surgeons and patients.   
 
Blinding of staff and patients 
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Blinding of staff and patients in surgical trials is a major challenge. It is, however, key to 
attempt this wherever possible to minimize performance and ascertainment bias. The use of 
large dressings to blind patients and staff to the type of incision and surgical access has been 
recently piloted in feasibility studies30. Whilst this was originally done in early surgical trials32 
it has been neglected in many recent studies. In our recent example the success of blinding 
has also been tested by asking participants and research personnel at the end of a trial 
whether they were aware of the participant’s allocation.33 The ROMIO (Randomized 
Oesophagectomy: Minimially Invasive or Open?) study34 (case study 2) demonstrated that 
blinding of patients and outcome assessors was possible, despite substantial differences 
between the two procedures under investigation (minimal access surgery versus standard 
open techniques). Although the most recent CONsolidated Standards Of Reporting Trials 
statement does not recommend testing for blinding success, it is possible that application of 
this test in surgical studies is particularly important to educate surgeons as they begin to 
observe that patients are unaware of their treatment allocation. More work is underway to 
develop methods to blind outcome assessors in RCTs comparing surgical and non-surgical 
interventions. A systematic review of RCTs in surgery is being undertaken to identify current 
methods used to blind staff. Future plans will involve making use of the recently developed 
collaborative networks (described above) to undertake follow up assessments of patients 
from each other’s centers. 
 
Selecting and standardizing interventions, and determining their acceptability 
Selecting the intervention groups to compare in an RCT requires consideration of existing 
evidence, current practice and emerging interventions to ensure that the findings of a future 
large trial would be up to date and relevant.35, 36 Sometimes, however, it is unclear what 
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constitutes current practice because new techniques are introduced and quickly become 
widely used – overtaking an evaluation and making results out-of-date before they become 
available. During the design of a trial, the use of surveys to characterize current practice is 
recommended in such situations. This approach was used in the Bluebelle study37 (case 
study 3; incidentally another study carried out by trainee surgical collaboratives), collecting 
data in the operating theatre prospectively across multiple centers for a representative 
sample of patients. Findings from this multicenter survey were surprising (for example, 
tissue adhesive was used ‘as a dressing’ in 27% of cases) and when combined with other 
data sources they resulted in a change in trial group interventions for the main study.38, 39  
Until recently, little attention has been paid to the complexity of surgical interventions. This 
complexity is multilayered and has several implications, particularly when determining what 
constitutes the intervention(s) and comparator(s) of interest and how they are described 
and standardized in trials. In order for surgeons to adopt trial findings, interventions need to 
be described in sufficient detail to enable accurate replication;40 however, this may not 
always be necessary or practical to provide.41 Careful standardization in a RCT may fail to 
reflect the inherent variation in clinical practice and consequently reduce the generalizability 
of the results. A compromise would be to determine an intervention’s ‘active ingredients’ – 
i.e. those that are thought to optimally influence outcomes or those which are different 
between the intervention and comparator in a trial – and the degree to which they need to 
be standardized. The Hub has developed new methods to explore the standardization of 
surgical interventions during the pilot phase of RCTs. These include development of a 
typology with which to deconstruct interventions into component parts (in order to consider 
which may need to be standardized), and qualitative data collection in the operating room 
(in order to understand how interventions are actually delivered and explore surgeons’ 
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views about standardization).42 The methods are currently being tested and refined within 
an RCT34 and observational study,43 to explore how the interventions might be described and 
standardized across different research settings.  
It is also important to ascertain the acceptability of the interventions under evaluation in an 
RCT. This may be particularly relevant in surgery because procedures and technology are 
constantly evolving and RCTs sometimes compare very different treatment groups, such as 
invasive versus non-invasive interventions. For example, there is emerging evidence that 
prophylactic appendectomy may reduce disease relapse in patients with ulcerative colitis. 
The ACCURE-UK study (case study 4)44 is conducting preliminary work to establish whether 
randomization to receive such an invasive intervention (compared with standard 
pharmacological treatment) is acceptable to patients and clinicians.    
 
Conclusion 
Surgical trials, particularly multicenter randomized studies, are essential to establish 
evidence based practice and inform health policy. Their design and conduct has historically 
been hampered by the lack of a collaborative research culture among surgeons and 
challenges posed by the surgical setting/context. Over the last five years, UK-based 
initiatives have made huge strides in establishing an infrastructure to address these 
methodological and cultural challenges. There has been a subsequent increase in the 
number of multicenter surgical RCTs, as well as a higher proportion of studies conducting 
vital preliminary work in order to understand the best ways to overcome barriers to RCTs 
and improve their quality. Surgical practice in the UK is now firmly on an upward trajectory 
to be based on evidence, rather than eminence.   
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Figure 1. Schema of the Royal College of Surgeons of England trials initiative 
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Case study 1 Assessing and addressing recruitment challenges: the By-Band-Sleeve 
Study45 
Background 
The prevalence of severe and complex obesity is increasing worldwide and surgery may 
offer an effective and lasting treatment. Laparoscopic adjustable gastric band and Roux-
en-Y gastric bypass surgery are the two main surgical procedures performed, accounting 
for approximately 80% of all obesity operations in the UK and the United States. However, 
it is uncertain which operation confers most benefit. An RCT comparing gastric band and 
bypass was perceived by many to be too difficult to conduct and recruit into because of 
strong preferences amongst surgeons that influence patient selection for surgery. 
What was done 
A pragmatic RCT with a preceding internal pilot phase was designed. Pilot work aimed to 
establish whether it was possible to recruit into this surgical trial using integrated 
qualitative methods. The integrated qualitative study consisted of the following: 
(a) A comprehensive process of logging of potential RCT participants through screening 
and eligibility phases will be used to monitor recruitment. Flow charts will be produced to 
show the degree of complexity of participation and any variations between centers. 
(b) In-depth semi-structured interviews to understand perspectives of participation were 
conducted with clinical and recruitment staff, and patients. Interviews provided data 
about: the perspectives of eligible patients; the evidence underlying the RCT, including the 
importance of the question and the commitment of staff to it, as well as individual clinical 
equipoise; the application of the protocol in clinical centers and any logistical issues; and 
suggestions about reasons for recruitment difficulties and potential solutions from those 
working closely within the RCT. These data formed the basis for feedback to recruiters and 
to determine the content of the information, and training programs to be initiated in 
Phase 2 of the RCT. 
What was found 
The qualitative recruitment intervention identified that surgeons needed training to 
communicate, i) uncertainty, ii) rationale for randomization, iii) the pros and cons of the 
treatment groups and iv) reasons for participation in the trial. Training was provided with 
group and individual feedback. 
Implications for the main trial 
The intervention let to increased recruitment in all centers. The progression criteria 
designed for the internal pilot were met. The funding body therefore approved expansion 
into the main trial. This has continued and recruitment remains close to being on time and 
target.  
 
RCT = randomized controlled trial 
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Case study 2 Achieving blinding of patients: the ROMIO study34, 46 
Background 
Surgery alone or in combination with chemotherapy or chemoradiation treatment is the 
mainstay of cure for localized esophageal cancer. There are several surgical approaches, 
and the past decade has seen a growing interest in minimal access surgical techniques 
with the potential advantages of causing less tissue trauma and better recovery. The 
primary outcome for the main trial is currently planned to be patient-reported physical 
fatigue, measured at several time points during the first three months after surgery. One 
of the aims of the pilot study was to develop and evaluate feasible, acceptable, and 
effective methods of blinding patients for the first week postoperatively, so reducing 
performance and outcome reporting biases. 
What was done 
A pilot study was conducted across two hospitals. Patients undergoing esophagectomy for 
cancer were randomized to receive totally minimally invasive surgery (laparoscopic 
abdomen and thoracoscopic chest), totally open surgery or a combination (laparoscopic 
abdomen and open chest). At the end of the procedure, surgeons placed dressings to 
cover open and minimally invasive surgery, irrespective of the surgical approach used. 
Dressings were left in place for five days post-operatively, to enable blinded outcome 
assessment up to this point. On the sixth day, point patients were asked to guess which 
operation they had received. 
What was found 
Most patients guessed that they had undergone the ‘combination’ approach irrespective 
of the group to which they were allocated, suggesting that blinding had been effective. 
The application (and replacement) of both open and laparoscopic dressings was found to 
be feasible and in most cases, it was possible to maintain blinding of patients for the first 
five postoperative days.  
Implications for the main trial 
This method of blinding patients has been successful and will therefore be used to reduce 
detection bias within the main study.  
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Case study 3 Selecting the interventions to be evaluated: the Bluebelle study37-39 
Background 
In the UK, wound dressings are routinely applied at the end of abdominal procedures in 
adults, yet dressings are scarcely used in pediatric populations. A systematic review 
concluded that there was no evidence to suggest that any dressing significantly reduced 
the risk of developing a surgical site infection compared with leaving wounds exposed; 
neither was there any benefit associated with particular dressing types. The National 
Institute for Health Research therefore commissioned work to examine whether an RCT of 
dressing vs no dressing would be possible. One of the critical uncertainties was selecting 
the interventions to be compared, because there are many different dressing types 
available.  
What was done 
A survey of current practice was undertaken across 20 UK hospitals over a two week 
period. Surgical trainees collected data in the operating theatre about the types of 
dressing used after abdominal surgery, and reasons why these were selected. Information 
relating to operative and patient factors that might influence this choice was also 
collected. 
What was found 
Data were collected from 724 patients and 1724 wounds. Although most wounds were 
covered with basic dressings (68%) following wound closure, an unexpectedly high 
number (27%) were covered with tissue adhesive (the study team were not aware that 
tissue adhesive was being used routinely). Surprisingly, no differences were found in the 
dressings used following planned and unscheduled surgery, between different types of 
surgery (including stoma formation), or according to patient characteristics (such as 
diabetes, co-morbidities). Surgeons tended to use the dressings that were handed to them 
at the end of the operation, rather than selecting specific dressings for clinical reasons. 
Implications for the main trial 
Given the survey findings, the main trial will now include tissue adhesive as a separate 
intervention group, to reflect routine practice. The inclusion criteria will also be widened 
to include patients undergoing unplanned operations.  
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Case study 4 Assessing the acceptability of interventions: the ACCURE-UK Study44 
Background 
Ulcerative colitis is a chronic inflammatory condition of the large bowel affecting more 
than 50,000 people in the UK, of whom around 40% will experience a relapse annually and 
25% requiring total colectomy in their lifetime. Ulcerative colitis patients can be treated 
with maintenance medical therapy; however, the annual disease relapse rate is around 
40% which requires escalation to high dose steroid medication with its incumbent risks 
and toxicity, or progression to a major colectomy operation. Research has shown that the 
appendix may affect the development and activity of ulcerative colitis. Several small 
studies in patients with active disease have found that appendectomy reduces relapse, 
hospitalization and medication usage, with the potential to prevent the need for future 
major surgery.  
The aim of the ACCURE-UK study was to explore whether appendectomy is an acceptable 
treatment option to ulcerative colitis patients and clinicians and if patients are willing to 
be randomized to a trial where appendectomy forms one of the treatment groups. It also 
aimed to establish the safety profile of therapeutic appendectomy in this novel 
population. 
What was done 
A multicenter randomized external pilot study was undertaken in which adult patients 
with an established diagnosis of ulcerative colitis, currently in remission, were included 
and randomised 1:1 to control group (standard medical treatment) or intervention 
(elective laparoscopic day case appendectomy plus standard medical treatment). 
Embedded qualitative research interviews, alongside recruitment targets and screening 
logs, were designed to ascertain acceptability (to both patients and clinicians) and verify 
the presence of an accessible cohort of eligible patients. 
What was found 
Of 106 patients approached, 60 (56.6%) were willing to be randomized. Overall 53 patients 
were randomised from 6 study sites. Recruitment took slightly longer than anticipated, 
but the target cohort of 48 patients was exceeded and the recruitment rate increased over 
time, with 25 patients recruited in the final two months. Appendectomy was completed as 
a day case in most cases with minor post-operative complications in four patients. 
Implications for the main trial 
The intervention was shown to be attractive to patients and clinicians, as well carrying 
minimal surgical morbidity. Patients with ulcerative colitis are willing to be randomized to 
such a trial and gastroenterologists and surgeons are keen to be involved. We have learnt 
how to access these patients and how to facilitate and streamline a complicated 
recruitment pathway. The success of the pilot study suggests that a large phase III trial 
exploring clinical effectiveness is feasible; a funding application for this full trial is 
underway. 
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